1. Anti-Vascular Endothelial Growth Factor Targeting by Curcumin and Thalidomide in Acute Myeloid Leukemia Cells

Volume 18, Issue 11, November 2017, Pages 3055-3061

Mahdieh Salemi; saeed mohammadi; Ardeshir Ghavamzadeh; Mohsen Nikbakht

• View Article
• PDF 878.25 K

2. Genistein Suppression of Matrix Metalloproteinase 2 (MMP-2) and Vascular Endothelial Growth Factor (VEGF) Expression in Mesenchymal Stem Cell Like Cells Isolated from High and Low Grade Gliomas

Volume 17, Issue 12, December 2016, Pages 5303-5307

Yasaman Yazdani; Mohammad Reza Sharifi Rad; Mousa Taghipour; Nooshafarin Chenari; Abbas Ghaderi; Mahboobeh Razmkhah

• View Article
• PDF 350.66 K

3. Prognostic Impact of Elevation of Vascular Endothelial Growth Factor Family Expression in Patients with Non-small Cell lung Cancer: an Updated Meta-analysis

Volume 16, Issue 5, May 2015, Pages 1881-1895

• View Article
• PDF 896.94 K

4. Pathologic Response During Chemo-radiotherapy and Variation of Serum VEGF Levels Could Predict Effects of Chemo-Radiotherapy in Patients with Esophageal Cancer

Volume 16, Issue 3, March 2015, Pages 1111-1116

• View Article
• PDF 562.5 K

5. Influence of Serum VEGF Levels on Therapeutic Outcome andDiagnosis/Prognostic Value in Patients with Cervical Cancer

Volume 15, Issue 20, December 2014, Pages 8793-8796

• View Article
• PDF 417.34 K

6. Prognostic Values of VEGF and Endostatin with Malignant Pleural Effusions in Patients with Lung Cancer

Volume 15, Issue 19, December 2014, Pages 8435-8440

• View Article
• PDF 695.23 K

7. Expression and Clinical Significance of MicroRNA-376a in Colorectal Cancer

Volume 15, Issue 21, December 2014, Pages 9523-9527

• View Article
• PDF 1.79 MB

8. Influence of Ionizing Radiation on Ovarian Carcinoma SKOV-3 Xenografts in Nude Mice under Hypoxic Conditions

Volume 15, Issue 5, May 2014, Pages 2353-2358

• View Article
• PDF 3.18 MB

9. Serum Tumor Markers, Hypoxia-Inducible factor-1α HIF-1α and Vascular Endothelial Growth Factor, in Patients with Nonsmall Cell Lung Cancer Before and after Intervention

Volume 14, Issue 6, June 2013, Pages 3851-3854

• View Article
• PDF 370.97 K

10. Expression and Significance of ER, PR, VEGF, CA15-3, CA125 and CEA in Judging the Prognosis of Breast Cancer

Volume 14, Issue 6, June 2013, Pages 3937-3940

• View Article
• PDF 421.13 K

11. Prognostic Value of Tissue Vascular Endothelial Growth FactorExpression in Bladder Cancer: a Meta-analysis

Volume 14, Issue 2, February 2013, Pages 645-649

• View Article
• PDF 554.62 K

12. Clinical Study of Tumor Angiogenesis and Perfusion Imaging Using Multi-slice Spiral Computed Tomography for Breast Cancer

Volume 14, Issue 1, January 2013, Pages 429-433

• View Article
• PDF 1.63 MB

13. Prognostic Value of Vascular Endothelial Growth Factor Expression in Patients with Prostate Cancer: a Systematic Review with Meta-analysis

Volume 13, Issue 11, November 2012, Pages 5665-5669

• View Article
• PDF 497.08 K

14. Tanshinone II-A Inhibits Angiogenesis through Down Regulation of COX-2 in Human Colorectal Cancer

Volume 13, Issue 9, September 2012, Pages 4453-4458

• View Article
• PDF 2.35 MB

15. Correlation of CT Perfusion Images with VEGF Expression in Solitary Brain Metastases

Volume 13, Issue 4, April 2012, Pages 1575-1578

• View Article
• PDF 813.88 K

16. Prognostic Factors for Overall Survival in Patients With Metastatic Colorectal Carcinoma Treated With Vascular Endothelial Growth Factor-Targeting Agents

Volume 13, Issue 3, March 2012, Pages 1059-1063

• View Article
• PDF 981.2 K

17. Norcantharidin Anti-Angiogenesis Activity Possibly through an Endothelial Cell Pathway in Human Colorectal Cancer

Volume 13, Issue 2, February 2012, Pages 499-503

• View Article
• PDF 1.84 MB

18. VEGFA +936C/T and -634G/C Polymorphisms and Gastric Cancer Risk: a Meta-analysis

Volume 12, Issue 8, August 2011, Pages 1979-1983

• View Article
• PDF 404.72 K